Intellia Therapeutics, Inc.
US ˙ NasdaqGM ˙ US45826J1051

SecurityNTLA / Intellia Therapeutics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership36,757 shares
Latest Disclosed Value $ 471,224
Citigroup Inc ownership in NTLA / Intellia Therapeutics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 36,757 shares of Intellia Therapeutics, Inc. (US:NTLA) valued at $471,225 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 231,156 shares of Intellia Therapeutics, Inc.. This represents a change in shares of -84.10% during the quarter. The current value of the position is $478,576 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (NTLA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NTLA / Intellia Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 36,757 -194,399 -84.10 471 -77.33 0.0001
2026-02-13 2025-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 231,156 141,488 157.79 2,078 34.24 0.0009
2025-11-10 2025-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 89,668 -55,113 -38.07 1,549 13.99 0.0007
2025-08-11 2025-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 144,781 -152,625 -51.32 1,358 -35.76 0.0007
2025-05-12 2025-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 297,406 20,476 7.39 2,115 -34.53 0.0011
2025-02-12 2024-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 276,930 109,370 65.27 3,229 -6.22 0.0019
2024-11-12 2024-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 167,560 59,178 54.60 3,443 41.98 0.0020
2024-08-12 2024-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 108,382 -234,584 -68.40 2,426 -74.30 0.0016
2024-05-10 2024-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 342,966 175,360 104.63 9,435 84.62 0.0062
2024-02-09 2023-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 167,606 -97,798 -36.85 5,110 -39.11 0.0036
2023-12-06 2023-09-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 265,404 94,363 55.17 8,392 20.32 0.0063
2023-11-09 2023-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 265,404 94,363 8,392 0.0025
2023-08-10 2023-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 171,041 14,953 9.58 6,975 19.91 0.0046
2023-05-11 2023-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 156,088 56,967 57.47 5,817 68.22 0.0041
2023-02-09 2022-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 99,121 -17,681 -15.14 3,458 -47.09 0.0028
2022-11-10 2022-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 116,802 15,307 15.08 6,536 24.42 0.0047
2022-08-10 2022-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 101,495 -237,291 -70.04 5,253 -78.66 0.0039
2022-05-12 2022-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 338,786 273,107 415.82 24,620 217.02 0.0150
2022-02-10 2021-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 65,679 -6,373 -8.85 7,766 -19.65 0.0042
2021-11-10 2021-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 72,052 5,239 7.84 9,665 -10.66 0.0057
2021-08-10 2021-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 66,813 -7,477 -10.06 10,818 81.45 0.0065
2021-05-13 2021-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 74,290 58,358 366.29 5,962 586.87 0.0039
2021-02-11 2020-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 15,932 -9,529 -37.43 868 71.54 0.0005
2020-11-12 2020-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 25,461 -15,295 -37.53 506 -40.96 0.0003
2020-08-12 2020-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 40,756 -3,203 -7.29 857 59.29 0.0007
2020-05-12 2020-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 43,959 -20,767 -32.08 538 -43.37 0.0005
2020-02-12 2019-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 64,726 -38,396 -37.23 950 -31.01 0.0007
2019-11-08 2019-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 103,122 54,587 112.47 1,377 73.21 0.0011
2019-08-12 2019-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 48,535 14,641 43.20 795 37.54 0.0006
2019-05-13 2019-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 33,894 -239,335 -87.60 578 -84.50 0.0006
2019-02-12 2018-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 273,229 127,275 87.20 3,730 -10.70 0.0038
2018-11-13 2018-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 145,954 45,432 45.20 4,177 51.89 0.0037
2018-08-10 2018-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 100,522 61,046 154.64 2,750 230.13 0.0025
2018-05-11 2018-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 39,476 -9,406 -19.24 833 -11.29 0.0007
2018-02-12 2017-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 48,882 48,882 939 0.0008
2017-11-13 2017-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 0 -152 -100.00 0 -100.00
2017-08-11 2017-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 152 81 114.08 2 100.00 0.0000
2017-05-12 2017-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 71 66 1,320.00 1 0.0000
2017-02-10 2016-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 5 -568 -99.13 0 -100.00
2016-11-10 2016-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 573 -130 -18.49 10 -33.33 0.0000
2016-08-12 2016-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 703 703 15 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-09 2023-12-31 13F INTELLIA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A INTELLIA THERAPEUTICS COM Call 100 3 n/a n/a n/a
2023-11-09 2023-09-30 13F INTELLIA THERAPEUTICS COM Call 100 3 n/a n/a n/a
2023-02-09 2022-12-31 13F INTELLIA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-10 2022-09-30 13F INTELLIA THERAPEUTICS COM Call 25,000 1,399 n/a n/a n/a
2020-08-12 2020-06-30 13F INTELLIA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-12 2020-03-31 13F INTELLIA THERAPEUTICS COM Call 2,800 -30.00 34 -42.37 n/a n/a n/a
2020-02-12 2019-12-31 13F INTELLIA THERAPEUTICS COM Call 4,000 -35.48 59 -28.92 n/a n/a n/a
2019-11-08 2019-09-30 13F INTELLIA THERAPEUTICS COM Call 6,200 -19.48 83 -34.13 n/a n/a n/a
2019-08-12 2019-06-30 13F INTELLIA THERAPEUTICS COM Call 7,700 234.78 126 223.08 n/a n/a n/a
2019-05-13 2019-03-31 13F INTELLIA THERAPEUTICS COM Call 2,300 -76.53 39 -70.90 n/a n/a n/a
2019-02-12 2018-12-31 13F INTELLIA THERAPEUTICS COM Call 9,800 -4.85 134 -54.58 n/a n/a n/a
2018-11-13 2018-09-30 13F INTELLIA THERAPEUTICS COM Call 10,300 27.16 295 32.88 n/a n/a n/a
2018-08-10 2018-06-30 13F INTELLIA THERAPEUTICS COM Call 8,100 5.19 222 37.04 n/a n/a n/a
2018-05-11 2018-03-31 13F INTELLIA THERAPEUTICS COM Call 7,700 162 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-09 2023-12-31 13F INTELLIA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A INTELLIA THERAPEUTICS COM Put 5,000 158 n/a n/a n/a
2023-11-09 2023-09-30 13F INTELLIA THERAPEUTICS COM Put 5,000 158 n/a n/a n/a
2023-02-09 2022-12-31 13F INTELLIA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-10 2022-09-30 13F INTELLIA THERAPEUTICS COM Put 25,000 1,399 n/a n/a n/a
2020-08-12 2020-06-30 13F INTELLIA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-12 2020-03-31 13F INTELLIA THERAPEUTICS COM Put 5,600 -78.29 68 -82.01 n/a n/a n/a
2020-02-12 2019-12-31 13F INTELLIA THERAPEUTICS COM Put 25,800 40.22 378 53.66 n/a n/a n/a
2019-11-08 2019-09-30 13F INTELLIA THERAPEUTICS COM Put 18,400 60.00 246 30.85 n/a n/a n/a
2019-08-12 2019-06-30 13F INTELLIA THERAPEUTICS COM Put 11,500 228.57 188 213.33 n/a n/a n/a
2019-05-13 2019-03-31 13F INTELLIA THERAPEUTICS COM Put 3,500 -2.78 60 22.45 n/a n/a n/a
2019-02-12 2018-12-31 13F INTELLIA THERAPEUTICS COM Put 3,600 -83.71 49 -92.26 n/a n/a n/a
2018-11-13 2018-09-30 13F INTELLIA THERAPEUTICS COM Put 22,100 84.17 633 92.99 n/a n/a n/a
2018-08-10 2018-06-30 13F INTELLIA THERAPEUTICS COM Put 12,000 42.86 328 85.31 n/a n/a n/a
2018-05-11 2018-03-31 13F INTELLIA THERAPEUTICS COM Put 8,400 177 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.